Sion Power Corporation and BASF today announced a Joint Development Agreement to accelerate the commercialization of Sion Power's proprietary lithium-sulfur battery technology, e.g., for the electric vehicle market and other high-energy applications.
The development team of Carbonlight Ltd promises that with the help of their new Nanointroscope not only the atom could be observed, but even the electron shells around an atom nucleus will be visible.
The Solution Processable Single Layer Graphene Oxide available from CheapTubes.com and the Graphene Nano Platelets (GNPs) are indeed very different products. Some products are inherently better suited for specific applications even though at first glance competing products may look very similar.
Oxford Instrument has announced the launch of CrystalFlex. This multi-wafer Hydride Vapour Phase Epitaxy (HVPE) reactor provides superb epitaxial growth control, and offers a cost effective route for the production of high quality, crack free epitaxial GaN, AlGaN and AlN single crystal materials.
Nanogen, Inc., developer of molecular and rapid diagnostic products, today announced that it has executed an asset purchase agreement with The Elitech Group, a privately held diagnostics company, to acquire substantially all of the assets of Nanogen. As part of the sale, Nanogen filed a voluntary petition under chapter 11.
Applied DNA Sciences, Inc., a provider of DNA-based security solutions, announced today that it has filed a patent for the embedment of DNA in cyanoacrylate, adding to its extensive intellectual property portfolio, and SigNature DNA product line.
Life Technologies Corporation, a provider of innovative life science solutions, and Zymera, Inc., today announced a licensing and supply agreement that gives Zymera rights to Life Technologies' extensive intellectual property estate related to quantum dots.
Die Nanostart-Beteiligung Nanosys Inc. und die QuantuMDx Group gaben den Abschluss einer nicht-exklusiven Lizenzvereinbarung fuer mehrere Patente und Patentanmeldungen fuer die Verwendung von Nanodraehten bei Biosensoren bekannt.
Genetic Immunity has announced that Julianna Lisziewicz, Chief Executive Officer of the Company, will be presenting at the Bio International Convention, to be held from May 18-21, 2009 in Atlanta, Georgia.
Nanosys Inc. and QuantuMDx Group (QMDx) today announced that QMDx has signed a non-exclusive license agreement with Nanosys for several patents and patent applications related to the use of nanowires for biosensors.